Trial
NCT06217094
Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Novatek; Florida Department of Health
Condition
Hepatocellular Carcinoma
Intervention
NP-101 (3 g)
Why stopped
funding terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-18